Entities / Company
MindMed.
business
- Reports this week
- 0
- Active events
- 0
- Connections
- 19
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
MindMed is developing medicines based on illegal compounds while strict federal laws restrict psychedelic compound use in Denver.Some support1 report
-
MindMed management participated in several industry conferences on August 28, 2025, including the Cantor Global Healthcare Conference and the H.C. Wainwright conference.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around MindMed this week
News at the entities that move MindMed most-
GAD OperationalThe FDA is reviewing a drug approval application for a condition involving the company GAD.Moves MindMed
-
New York City Shared contextJoint entities are driving a high volume of General Obligation bond issuance in New York City.Moves MindMed
-
North America Shared contextAn inaugural rodeo was held in Cape Breton, featuring athletes who represented North America.Moves MindMed
-
Europe Shared contextThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves MindMed
Connections
The 5 strongest of 19, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Voyage Structural
MindMed sponsors the Voyage clinical trial, which tests its MM120 ODT drug.
-
GAD Operational
MindMed is actively conducting clinical studies and trials targeting GAD treatment.
-
New York City Shared context
MindMed operates from its headquarters located in New York City.
-
North America Shared context
MindMed operates research facilities within the North American region.
-
Europe Shared context
MindMed operates research facilities within the geographical context of Europe.